MedTrace Logo

Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer

NCT05221684 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-02-03

No results posted yet for this study

Summary

This study aims to evaluate the value of the LNR as a prognostic indicator in patients with rectal cancer who offered total mesorectal excision.

Conditions

  • Recurrence

Interventions

PROCEDURE

Lymph node harvesting

Lymph node harvesting after radical resection for rectal cancer with curative intent

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Mostafa Shalaby · Mansoura Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-09
Primary Completion
2022-01-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05221684 on ClinicalTrials.gov